# Pretreatment With Unfractionated Heparin for ST Elevation Myocardial Infarction

Study · id `cardio:ct-nct05247424` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05247424](<https://clinicaltrials.gov/study/NCT05247424>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05247424

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 600 participants.

## Technical summary

Registry record NCT05247424. Randomized; single masking; primary purpose treatment. Start 2022-03-10 (actual); primary completion 2025-02-05 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 600 participants (enrolled count; ClinicalTrials.gov record NCT05247424, source copy `cardio:ctgov-nct05247424-2025-05-01`, retrieved 2026-10-26)
- Started: 2022-03-10 (actual) (ClinicalTrials.gov record NCT05247424, source copy `cardio:ctgov-nct05247424-2025-05-01`, retrieved 2026-10-26)
- Primary completion: 2025-02-05 (actual) (ClinicalTrials.gov record NCT05247424, source copy `cardio:ctgov-nct05247424-2025-05-01`, retrieved 2026-10-26)
- Completion: 2025-03-05 (actual) (ClinicalTrials.gov record NCT05247424, source copy `cardio:ctgov-nct05247424-2025-05-01`, retrieved 2026-10-26)
- Countries: Slovenia (ClinicalTrials.gov record NCT05247424, source copy `cardio:ctgov-nct05247424-2025-05-01`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05247424-2025-05-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: Pretreatment With Unfractionated Heparin for ST Elevation Myocardial Infarction
- Acronym: UFH-STEMI
- Condition: STEMI - ST Elevation Myocardial Infarction
- Intervention (Drug): Unfractionated heparin
- Lead sponsor: University Medical Centre Ljubljana
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry intervention name matches this record: Heparins and low-molecular-weight heparins (`cardio:heparins-and-low-molecular-weight-heparins`)
- Registry intervention is a member of this class by a sourced record link: Anticoagulants (`cardio:anticoagulants`)
- Registry lists this organization as the lead sponsor: University Medical Centre Ljubljana (`cardio:org-university-medical-centre-ljubljana`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Prehospital Heparin Administration in Patients With STEMI Undergoing Primary PCI: HEPARIN-STEMI Randomized Controlled Trial (`cardio:pubmed-41910504`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 3cc0e2a5e4d047d58e808e936df470557474c26d9f4e47fc3bbb068e1a5b97c8
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
